OBJECTIVE To study the preparation and stability of piroxicam cream.
目的吡罗昔康乳膏的研制及稳定性研究。
ObjectiveTo study the preparation of piroxicam cream and its stability.
目的吡罗昔康乳膏的制备及稳定性研究。
OBJECTIVE to investigate the transdermal iontophoresis of piroxicam gel in vitro.
目的考察吡罗昔康凝胶的体外经皮离子导入。
Objective: To investigate the suspension of inclusion compound of piroxicam nasal absorption.
目的：研究吡罗昔康包合物混悬液的鼻粘膜吸收。
Therefore, it provide experimental basis on the clinical use of Piroxicam to prevent gastric cancer.
这些结果从细胞免疫方面为吡罗昔康能够防治胃癌提供了一定的实验依据。
CONCLUSION the property of piroxicam cream was stable and reached the standard of the quality requirements.
结论吡罗昔康乳膏性质稳定，达到了质量标准的要求。
CONCLUSION: Piroxicam patch shows better efficacy and similar safety in the treatment of acute and chronic pain in comparing with diclofenac.
结论：吡罗昔康贴片治疗急慢性疼痛多项疗效指标结果优于双氯芬酸乳胶，安全性与双氯芬酸乳胶相似。
The European Medicines Agency (EMEA) has recently completed a review of the safety of the non-steroidal anti-inflammatory drug (NSAID) piroxicam.
欧洲药品管理局(emea)最近完成了有关非类固醇抗炎药(NSAID)吡罗昔康的安全性评价。
In addition, the CHMP has concluded that piroxicam-containing medicines should no longer be used for the treatment of acute (short-term) pain and inflammation.
此外，CHMP的结论还指出，含有吡罗昔康的药物不应再用于急性(短期)疼痛和炎症的治疗。
Piroxicam is a NSAID, a medicine used to treat inflammation. It has been available on the market for many years and has been used in the treatment of many painful conditions.
吡罗昔康是一种用于治疗炎症的非类固醇抗炎药，该药物已上市多年并用于治疗多种疼痛症状。
In addition, the CHMP added some contraindications and strengthened warnings for piroxicam, to ensure that it is not used in patients who are at a higher risk of developing side effects.
此外，CHMP还增加了吡罗昔康某些禁忌症并强调了警告信息，以确保不用于那些出现副作用的高危患者。
Complexes intended to release an activesubstance that is entrapped by the complex in the blood circulation orelsewhere. Examples of such complexes are e. g. piroxicam betadex or nicotinebetadex.
用于释放活性物质的复合物，该复合物将活性物质限制在血液循环中或其它地方，这种复合物的例子如吡罗昔康倍他环糊精复合物或尼古丁倍他环糊精复合物。
Complexes intended to release an activesubstance that is entrapped by the complex in the blood circulation orelsewhere. Examples of such complexes are e. g. piroxicam betadex or nicotinebetadex.
用于释放活性物质的复合物，该复合物将活性物质限制在血液循环中或其它地方，这种复合物的例子如吡罗昔康倍他环糊精复合物或尼古丁倍他环糊精复合物。
应用推荐